Skip to main content
Clinical Trials/NCT00966316
NCT00966316
Completed
Phase 4

Establishment and Evaluation to the Effects of a Clinical Pathway for Acute Ischemic Stroke

Guangzhou University of Traditional Chinese Medicine1 site in 1 country314 target enrollmentMay 2009

Overview

Phase
Phase 4
Intervention
aspirin,chinese herbs;
Conditions
Acute Ischemic Stroke
Sponsor
Guangzhou University of Traditional Chinese Medicine
Enrollment
314
Locations
1
Primary Endpoint
death rate;average hospital day;cost of hospitalization
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

The purpose of this study is to determine whether the clinical pathway for acute ischemic stroke(with combination of traditional Chinese medicine and western medicine) is able to improve the outcome of acute ischemic stroke and evaluate its effect on hospital day and cost, etc. Meanwhile, the study will discuss the safety and efficiency of this kind of Clinical Pathway

Detailed Description

Eligibility Ages Eligible for Study: 18 Years to 85 Years Genders Eligible for Study: Both Accepts Healthy Volunteers: No Criteria Inclusion Criteria: Those clinically diagnosed with acute ischemic stroke ; 18-85 years old; Over 6 hours and within 14 days from onset 4\<=NIHSS \<=22; Informed consent signed by patient or his/her family ; Exclusion Criteria: Hemorrhagic stroke; Cerebral hernia; Serious heart, liver, lung, kidney functional failure,malignancy; Not cooperative with physician; Psychological disorder; Already taken part in other clinical drug trial within the past 3 months

Registry
clinicaltrials.gov
Start Date
May 2009
End Date
January 2011
Last Updated
14 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Ischemic stroke diagnosed with both criteria of traditional Chinese medicine and western medicine;
  • 18-85 years old;
  • Over 6 hours and within 14 days from onset
  • 4\<=NIHSS \<=22;
  • Informed consent signed by patient or his/her family ;

Exclusion Criteria

  • Hemorrhagic stroke;
  • Cerebral hernia;
  • Serious heart, liver, lung, kidney functional failure,malignancy;
  • Not cooperative with physician;
  • Psychological disorder;
  • Already taken part in other clinical drug trial within the past 3 months

Arms & Interventions

pathway

aspirin,Chinese herbs;acupuncture;rehabilitation;health education;

Intervention: aspirin,chinese herbs;

Outcomes

Primary Outcomes

death rate;average hospital day;cost of hospitalization

Time Frame: 3 months;discharge day

Secondary Outcomes

  • Modified Rankin Scale (mRS) National Institute of Health Stroke Scale (NIHSS) Barthel Index degree of satisfaction(7 day;30 day;3 months)

Study Sites (1)

Loading locations...

Similar Trials